Cytokinetics
CYTK
#2280
Rank
A$12.08 B
Marketcap
A$98.87
Share price
-1.31%
Change (1 day)
26.52%
Change (1 year)

Revenue for Cytokinetics (CYTK)

Revenue in 2025 (TTM): A$0.13 Billion

According to Cytokinetics 's latest financial reports the company's current revenue (TTM ) is A$0.13 Billion. In 2024 the company made a revenue of A$29.7 Million an increase over the revenue in the year 2023 that were of A$11.05 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cytokinetics from 2003 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) A$0.13 B351.75%
2024 A$29.7 M168.73%
2023 A$11.05 M-92.05%
2022 A$0.13 B43.08%
2021 A$97.14 M33.8%
2020 A$72.6 M89.2%
2019 A$38.37 M-14.18%
2018 A$44.71 M161.14%
2017 A$17.12 M-88.4%
2016 A$0.14 B275.25%
2015 A$39.33 M-31.41%
2014 A$57.35 M66.93%
2013 A$34.35 M372.37%
2012 A$7.27 M86.46%
2011 A$3.9 M53.83%
2010 A$2.53 M-97.21%
2009 A$90.76 M415.6%
2008 A$17.6 M12.99%
2007 A$15.58 M292.78%
2006 A$3.96 M-67.43%
2005 A$12.17 M-29.88%
2004 A$17.37 M21.91%
2003 A$14.24 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Ligand Pharmaceuticals
LGND
A$0.37 B 188.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
A$0.82 M-99.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$0.17 B 32.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$54.15 B 41,145.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
A$2.00 B 1,428.85%๐Ÿ‡บ๐Ÿ‡ธ USA